Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

406 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of doxorubicin plus cyclophosphamide on left ventricular ejection fraction in patients with breast cancer in the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial.
Perez EA, Suman VJ, Davidson NE, Kaufman PA, Martino S, Dakhil SR, Ingle JN, Rodeheffer RJ, Gersh BJ, Jaffe AS. Perez EA, et al. Among authors: davidson ne. J Clin Oncol. 2004 Sep 15;22(18):3700-4. doi: 10.1200/JCO.2004.03.516. J Clin Oncol. 2004. PMID: 15365066 Clinical Trial.
Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization.
Passos-Coelho JL, Braine HG, Davis JM, Huelskamp AM, Schepers KG, Ohly K, Clarke B, Wright SK, Noga SJ, Davidson NE, et al. Passos-Coelho JL, et al. Among authors: davidson ne. J Clin Oncol. 1995 Mar;13(3):705-14. doi: 10.1200/JCO.1995.13.3.705. J Clin Oncol. 1995. PMID: 7533827 Clinical Trial.
Similar breast cancer cell contamination of single-day peripheral-blood progenitor-cell collections obtained after priming with hematopoietic growth factor alone or after cyclophosphamide followed by growth factor.
Passos-Coelho JL, Ross AA, Kahn DJ, Moss TJ, Davis JM, Huelskamp AM, Noga SJ, Davidson NE, Kennedy MJ. Passos-Coelho JL, et al. Among authors: davidson ne. J Clin Oncol. 1996 Sep;14(9):2569-75. doi: 10.1200/JCO.1996.14.9.2569. J Clin Oncol. 1996. PMID: 8823337
Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer.
ten Bokkel Huinink W, Gore M, Carmichael J, Gordon A, Malfetano J, Hudson I, Broom C, Scarabelli C, Davidson N, Spanczynski M, Bolis G, Malmström H, Coleman R, Fields SC, Heron JF. ten Bokkel Huinink W, et al. J Clin Oncol. 1997 Jun;15(6):2183-93. doi: 10.1200/JCO.1997.15.6.2183. J Clin Oncol. 1997. PMID: 9196130 Clinical Trial.
Primary systemic therapy in operable breast cancer.
Wolff AC, Davidson NE. Wolff AC, et al. Among authors: davidson ne. J Clin Oncol. 2000 Apr;18(7):1558-69. doi: 10.1200/JCO.2000.18.7.1558. J Clin Oncol. 2000. PMID: 10735905 Review.
New data on adjuvant therapy for breast cancer.
Wolff AC, Davidson NE. Wolff AC, et al. Among authors: davidson ne. Curr Oncol Rep. 1999 Sep;1(1):31-7. doi: 10.1007/s11912-999-0007-5. Curr Oncol Rep. 1999. PMID: 11122795 Review.
406 results